These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17602295)

  • 1. The organization and financing of end-stage renal disease in Spain.
    Luño J
    Int J Health Care Finance Econ; 2007 Dec; 7(4):253-67. PubMed ID: 17602295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The financing and organization of medical care for patients with end-stage renal disease in Sweden.
    Wikström B; Fored M; Eichleay MA; Jacobson SH
    Int J Health Care Finance Econ; 2007 Dec; 7(4):269-81. PubMed ID: 17657602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The organization and financing of dialysis and kidney transplantation services in New Zealand.
    Ashton T; Marshall MR
    Int J Health Care Finance Econ; 2007 Dec; 7(4):233-52. PubMed ID: 17638073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The organization and financing of kidney dialysis and transplant care in the United States of America.
    Hirth RA
    Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Study of Health Care Organization and Financing of renal services in England and Wales.
    Nicholson T; Roderick P
    Int J Health Care Finance Econ; 2007 Dec; 7(4):283-99. PubMed ID: 17653861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).
    Dor A; Pauly MV; Eichleay MA; Held PJ
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):73-111. PubMed ID: 17653860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The organization and financing of end-stage renal disease treatment in Japan.
    Fukuhara S; Yamazaki C; Hayashino Y; Higashi T; Eichleay MA; Akiba T; Akizawa T; Saito A; Port FK; Kurokawa K
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):217-31. PubMed ID: 17690980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.
    Pontoriero G; Pozzoni P; Vecchio LD; Locatelli F
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):201-15. PubMed ID: 17641969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Study of Health Care Organization and Financing for end-stage renal disease in France.
    Durand-Zaleski I; Combe C; Lang P
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):171-83. PubMed ID: 17680359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.
    Manns BJ; Mendelssohn DC; Taub KJ
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):149-69. PubMed ID: 17641968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International study of health care organization and financing: development of renal replacement therapy in Germany.
    Kleophas W; Reichel H
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):185-200. PubMed ID: 17701342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK
    N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of chronic kidney disease care in southeast Asia.
    Jha V
    Semin Nephrol; 2009 Sep; 29(5):487-96. PubMed ID: 19751894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.
    Sandoz MS; Ess SM; Keusch GW; Schwenkglenks M; Szucs TD
    Swiss Med Wkly; 2004 Aug; 134(31-32):448-58. PubMed ID: 15389348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-cost life prolongation: the National Kidney Dialysis and Kidney Transplantation Study.
    Gutman RA
    Ann Intern Med; 1988 Jun; 108(6):898-9. PubMed ID: 3285750
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal disease in Colombia.
    Gómez RA
    Ren Fail; 2006; 28(8):643-7. PubMed ID: 17162422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplantation costs: an economic analysis and comparison with dialysis costs.
    Aranzabal J; Pérdigo L; Mijares J; Villar F
    Transplant Proc; 1991 Oct; 23(5):2574. PubMed ID: 1926487
    [No Abstract]   [Full Text] [Related]  

  • 20. The databases: renal replacement therapy since 1989--the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA).
    Zoccali C; Kramer A; Jager K
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S18-22. PubMed ID: 19996000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.